ABSTRACT Phospholipase A 2 (PLA 2 ), a common toxic component of snake venom, has been implicated in various pharmacological effects. Ecarpholin S, isolated from the venom of the snake Echis carinatus sochureki, is a phospholipase A 2 (PLA 2 ) belonging to the Ser 49 -PLA 2 subgroup. It has been characterized as having low enzymatic but potent myotoxic activities. The crystal structures of native ecarpholin S and its complexes with lauric acid, and its inhibitor suramin, were elucidated. This is the first report of the structure of a member of the Ser 49 -PLA 2 subgroup. We also examined interactions of ecarpholin S with phosphatidylglycerol and lauric acid, using surface plasmon resonance, and of suramin with isothermal titration calorimetry. Most Ca 21 -dependent PLA 2 enzymes have Asp in position 49, which plays a crucial role in Ca 21 binding. The three-dimensional structure of ecarpholin S reveals a unique conformation of the Ca 21 -binding loop that is not favorable for Ca 21 coordination. Furthermore, the endogenously bound fatty acid (lauric acid) in the hydrophobic channel may also interrupt the catalytic cycle. These two observations may account for the low enzymatic activity of ecarpholin S, despite full retention of the catalytic machinery. These observations may also be applicable to other non-Asp 49 -PLA 2 enzymes. The interaction of suramin in its complex with ecarpholin S is quite different from that reported for the Lys 49 -PLA 2 /suramin complex , where the interfacial recognition face (i-face), C-terminal region, and N-terminal region of ecarpholin S play important roles. This study provides significant structural and functional insights into the myotoxic activity of ecarpholin S and, in general, of non-Asp 49 -PLA 2 enzymes.
INTRODUCTION
Phospholipase A 2 (PLA 2 , enzyme classification number 3.1.1.4) enzymes constitute a large family of hydrolases that catalyze the hydrolysis of the sn-2 ester bond of phospholipids, producing free fatty acids and lysophospholipids (1) (2) (3) (4) (5) . The PLA 2 superfamily was classified into 11 groups (6) . The PLA 2 enzymes of groups I and II are major components of snake venom in the Elapidae and Viperidae families, respectively. Both groups exhibit Ca 21 -dependent enzymatic activity, with Ca 21 binding to a Ca 21 -binding loop and Asp 49 (according to the numbering system of Renetseder et al. (7)). Although a majority of group II PLA 2 enzymes have Asp at their position 49, this residue can occasionally be substituted with nonacidic residues such as Lys, Ser, Asn, and Arg (8) (9) (10) . As expected, Asp 49 -PLA 2 enzymes show high catalytic activity, whereas non-Asp 49 -PLA 2 enzymes show low or no enzymatic activity. Interestingly, these non-Asp 49 -PLA 2 enzymes exhibit strong myotoxic activity. Extensive research has been devoted to understanding the structure and function of Lys 49 -PLA 2 enzymes. In Lys 49 -PLA 2 enzymes, the Ne atom of Lys 49 occupies the space of the essential Ca 21 ion in Asp 49 -PLA 2 enzymes, resulting in a substantial loss of catalysis (11, 12) . Furthermore, some studies suggest that a fatty-acid molecule may lie in the hydrophobic channel, leading to the interruption of catalytic cycles (13, 14) . The myotoxic/cytolytic site of Lys 49 -PLA 2 enzymes was identified using synthetic peptides (15) (16) (17) . Subsequent studies using inhibition by heparin, chemical modification, and site-directed mutagenesis strongly supported the role of the C-terminal region in myotoxic activity, as reviewed in detail elsewhere (18) . The positively charged patch on the surface of Lys 49 -PLA 2 was suggested to play an active role in myotoxic activity (19, 20) . Ambrosio et al. (21) proposed that electrostatic interactions involving the C-terminal lysine residues play a role in the insertion of the hydrophobic ''knuckle'' induced by Lys 122 into the membrane. So far, most of the structural and functional studies of nonAsp 49 -PLA 2 enzymes focused on Lys 49 -PLA 2 enzymes. On the other hand, little is known about Ser 49 -PLA 2 and other non-Asp 49 -PLA 2 enzymes. Here we report on the enzymatic activity and myotoxic activity of a Ser 49 -PLA 2 (ecarpholin S) from the venom of the snake Echis carinatus sochureki. We also determined crystal structures of ecarpholin S in its native form and in complexes with lauric acid, and of its myotoxic inhibitor, suramin. This is the first representative structure of the Ser 49 -PLA 2 subgroup. Moreover, the mechanism of action of Ser 49 -PLA 2 is elucidated, using structural data combined with biochemical and biophysical studies.
lowing the protocol of Polgar et al. (22) , with minor modifications. Lyophilized venom was dissolved at 100 mg/mL in 50 mM Tris-HCl buffer, pH 7.0. Soluble components were loaded onto a Superdex 200 gel-filtration column (1.0 3 60 cm, Amersham Biosciences, Uppsala, Sweden) eluted with the same buffer. The sixth peak, estimated to have a molecular mass of ;14 kDa, was loaded onto an SP Sepharose High Performance cation-exchange column (5 mL, Amersham Biosciences). Ecarpholin S was eluted as a main peak from this column. We isolated ScPLA 2 (belonging to the Asp 49 -PLA 2 subgroup) from E. c. sochureki venom according to the protocol of Jasti et al. (23) . Both isolated proteins were confirmed by mass spectrometry and N-terminal sequencing. Suramin (8, 89 -[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid hexasodium), phosphatidyglycerol (from egg yolk), and lauric acid were obtained from Sigma Chemical Co. (St. Louis, MO). All other reagents were of analytical grade.
Phospholipase enzymatic activity
The enzymatic activity of PLA 2 was measured by routine colorimetric assay, using a 1,2-dithio analog of diheptanoylphosphatidylcholine as substrate (PLA 2 assay kit, Cayman Chemicals, Ann Arbor, MI). The ScPLA 2 from E. c. sochureki served as positive control.
Myotoxic activity
Myotoxic activity is the damage to skeletal muscle leading to the release of cellular contents and the death of muscle cells. A number of snake venom proteins were shown to induce myotoxicity (18) . Groups of five Swiss albino mice (18-22 g body weight) were injected (intramuscularly to the right gastrocnemius muscle) with 50, 75, or 100 mg of ecarpholin S in 50 mL of phosphate-buffered saline (PBS). After 3 h, the mice were anesthetized, and their blood was collected via heart puncture. The creatine kinase (CK) activity of serum was then measured using a kit (No. 2910) from Stanbio Laboratory (Boerne, Texas). One unit was defined as the amount of enzyme that produces 1 mmol of NADPH/min, and activity was expressed in units/liter. In inhibition studies, different doses of suramin were incubated with ecarpholin S (100 mg/mouse) for 15 min at 37°C before administration to animals.
Edema-inducing activity
The accumulation of fluid in the interstitial space and swelling during the inflammatory response are measured as edema. The PLA 2 from snake venom is a potent mediator of edema (5, 24) . The edema-inducing effects of ecarpholin S were measured in mice, as described earlier (25) . Different doses of ecarpholin S were dissolved in 20 mL of PBS (pH 7.5) and administered via subplantar injection into the left footpad of Swiss albino mice under anesthesia. After 1 h, while still under anesthesia, mice were sacrificed by inhalation of carbon dioxide. Both their feet (injected and uninjected) were severed just above the plantar joint, and weighed. The percentage of edema was calculated from the difference in weight between injected and uninjected feet, with PBS as the control.
Isothermal titration calorimetry (ITC)
Ecarpholin S titrations with suramin were performed on a VP-ITC calorimeter system (MicroCal LLC, Northampton, MA) at 30°C. Solutions of 0.03 mM of ecarpholin S in 50 mM Tris-HCl (pH 7.4) were titrated with 0.5 mM suramin dissolved in the same buffer. The reaction cell contained 1.5 mL of the protein solution in buffer. Suramin was added in 5-mL increments at 500-s intervals. Injections of suramin solution in the same buffer, but in the absence of protein, were used to account for the heats of mixing and dilution. Binding parameters were estimated from isotherms obtained using scripts (Origin 7.0, OriginLab, Northampton, Massachusetts) developed in our laboratory.
Surface plasmon resonance
Surface plasmon resonance (SPR) studies were performed with Biacore 3000 (Biacore AB, Uppsala, Sweden). We prepared phosphatidyglycerol (PG) liposomes by sonication, as previously described (26) . Briefly, an appropriate amount of PG (2 mg) was dissolved in 2 mL of a chloroform solution, and the organic solvent was subsequently removed by vacuum desiccation. The resultant dried lipid film was rehydrated with PBS (pH 7.4) at the appropriate concentration at 25°C for 2 h. The resulting aqueous lipid mixture was sonicated until the solution appeared optically transparent in white light. A homogeneous liposomal suspension of approximately uniformly sized unilamellar vesicles with an average diameter (from dynamic light-scattering measurement) of 45 6 7 nm was obtained. We performed immobilization of the PG liposome on the L1 chip, as described by the manufacturer. Briefly, PBS (pH 6.8) was used as the running buffer, the washing solution was 40 mM N-octyl b-D-glucopyranoside, and the regenerating solution was 10 mM NaOH. Experiments were performed at 25°C. Phosphatidyglycerol unilamellar vesicles (100 mL, 1 mM) were applied to the chip surface at a low flow rate (2 mL/min). To remove any multilamellar structures from the lipid surface, we injected NaOH (50 mL, 10 mM) at a flow rate of 50 mL/min, which resulted in a stable baseline corresponding to the lipid bilayer linked to the chip surface. The negative-control bovine serum albumin was injected (50 mL, 0.1 mg/mL in PBS) to confirm complete coverage of nonspecific binding sites. Ecarpholin S was diluted into a suitable final concentration, using the running buffer. All sensorgrams were processed by using automatic correction for nonspecific bulk refractive index effects. The equilibrium constant (K D ) was determined by the 1:1 Langmuir binding fitting model provided by the Biacore 3000 instrument software.
To study the interaction between ecarpholin S and lauric acid, ecarpholin S was immobilized on the sensor chip CM5 (Biacore AB) by the standard primary amine-coupling reaction. The equilibration of baseline was completed by the continuous flow of HBS-EP running buffer (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, and 0.005% (v/v) surfactant P20, pH 7.4) through the chip. One of the four serial flow cells was activated for 10 min by injecting a 1:1 fresh mixture of 0.2 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 50 mM N-hydroxysuccinimide (NHS) at 25°C. Ecarpholin S was diluted with 10 mM HEPES buffer (pH 7.5) at a concentration of 50 mg/mL, and immobilized to the surface of sensor chip CM5. Finally, unreacted groups were blocked by injecting 1 M ethanolamine-HCl at pH 8.5 for 7 min, resulting in immobilized densities of 3500 RU. After stabilizing the baseline, Biacore data were collected at 25°C at a constant flow of 20 mL/min. Lauric acid was diluted into a suitable final concentration, using the running buffer. We used 70% ethanol as regeneration buffer. The equilibrium constant (K D ) was determined by the 1:1 Langmuir binding fitting model.
Crystallization and data collection
Ecarpholin S was crystallized by hanging-drop vapor-diffusion method using screens from Hampton Research (Aliso Viejo, CA). All crystallization experiments were performed at room temperature, with drops containing equal volumes (1 mL) of reservoir and protein solution. The protein was kept in a buffer of 50 mM Tris-HCl, pH 7.4, at a concentration of 10 mg/mL. The apo ecarpholin S crystal belonged to the space group P2 1 2 1 2 1 and was grown from a condition of 20% w/v polyethylene glycol (PEG) 3350, 20% v/v isopropanol, and 0.1 M sodium citrate, pH 5.6. Crystals of natural ecarpholin S/fatty-acid complex were crystallized in the presence of 2 M ammonium sulfate, 0.1 M Tris-HCl, pH 8.5, and belonged to the space group P3 1 21. Ecarpholin S/suramin complex crystals were obtained using 10% w/v PEG3350, 10% v/v iso-propanol, and 0.1 M sodium citrate, pH 5.6, with a molar ratio of suramin/protein at 3:2. These crystals belonged to the space group P2 1. Before the collection of x-ray diffraction data, crystals were soaked in increasing steps of glycerol concentration (5% increase in each step; 30 min per step), and the final glycerol concentration was ;20% before flash-freezing using liquid N 2 . The x-ray diffraction data for the apo and suramin complex were collected using an R-axis IV 21 image plate detector mounted on a RU-H3RHB rotating anode generator (Rigaku Corp., Tokyo, Japan). The data for the fatty-acid complex were collected at the X29 beamline (National Synchrotron Light Source (NSLS), Brookhaven National Laboratory, New York), using a Q315 CCD detector (Area Detector Systems Corp., Poway, CA). All data sets were processed using the HKL2000 suite (27) . Crystallographic statistics are shown in Table 1 .
Structural determination and refinement
Initial phases for apo ecarpholin S were obtained by the molecular replacement method with Molrep (28), using the Asp 49 -PLA 2 structure from Agkistrodon halys Pallas as a search model (Protein Data Bank code 1JIA; sequence identity, ;56%). The initial R work was 52%, and subsequent automodel building was performed with ARP/wARP (29) . The resultant model with the electron-density map was examined, and the model was built with the O program (30) . Structures of the lauric acid and suramin complexes were determined using the apo ecarpholin S structure as the initial search model for the molecular replacement method, using the program Molrep (28) . Omit maps were calculated for positioning the ligand. All three model-buildings and refinements were performed using O (30) and CNS (31) programs, with appropriate entries in their respective dictionaries. The overall geometry of the final models was analyzed by PROCHECK (32) . Refinement statistics are given in Table 1 .
RESULTS

Characterization of ecarpholin S
Ammodytin L, the first known Ser 49 -PLA 2 isolated from the snake venom of Vipera ammodytes, was initially reported to exhibit low enzyme activity (33) . However, this activity was later attributed to contamination with ammodytoxins (34). Polgar et al. (22) reported that Ser 49 -PLA 2 ecarpholin S had 1.5-2.9 times more enzymatic activity than the recombinant human group II PLA 2 . Our study shows that ecarpholin S has enzymatic activity (0.1 mmol/min/mg). However, compared with the activity of scPLA 2, an Asp 49 -PLA 2 from the same venom, ecarpholin S shows only 0.5% activity (24.5 mmol/ min/mg; see Fig. S1 in Supplementary Material, Data S1). Thus it is tempting to conclude that the activity of ecarpholin S is similar to that of some Lys 49 -PLA 2 enzymes, which have low catalytic ability (35) (36) (37) (38) (39) (40) (41) .
Ecarpholin S is a basic PLA 2 (calculated pI ¼ 8.4), with several conserved, positively charged residues (particularly lysine) that are thought to be important in the myotoxicity of low molecular mass PLA 2 enzymes. Hence ecarpholin S was predicted to have myotoxic activity (22, 42) . Our results confirmed that ecarpholin S does exhibit myotoxic activity. Intramuscular injections of ecarpholin S increased serum *R sym ¼ +jI i À AEIaej/+jIj, where I i is the intensity of the ith measurement, and AEIae is the mean intensity for that reflection. y R work ¼ +jF obs -F calc j/+jF obs j, where F calc and F obs are the calculated and observed structure factor amplitudes, respectively. z R free ¼ R work , but for 10% of the total reflections randomly selected and omitted from refinement. § Individual B-factor refinement was performed.
creatine kinase (CK) levels in a dose-dependent manner (Fig.  1 ). The injection of ecarpholin S at a dose of 100 mg/mouse induced a significant increase in serum CK activity from 160 (6 40) units/L (mean 6 SD, n ¼ 5) to 1900 (6 400) units/L (n ¼ 5), compared with physiological saline solution (PBS, pH 7.3). Injecting ecarpholin S into the footpad of mice induced mild edema. At 20 mg/mouse, ecarpholin S induced ;20% edema compared with PBS-injected control mice ( Fig. S2 in Data S1).
Structure of apo ecarpholin S
Although structures of a number of Asp 49 and Lys 49 PLA 2 enzymes are known, to date, no structure has been available for Ser 49 PLA 2 enzymes. Therefore, we determined the structure of ecarpholin S. The structure of its apo-form was solved by the molecular replacement method, using the Asp 49 -PLA 2 structure from Agkistrodon halys Pallas as a starting model, and refined to an R work of 19.2% (R free ¼ 25.4%) up to 2.0-Å resolution. The model was refined with good stereochemical parameters ( Table 1) . Statistics for the Ramachandran plot from an analysis using PROCHECK (32) gave 90.4% of nonglycine residues in the most favored region, and no residues in the disallowed region.
The overall structure of ecarpholin S resembles that of classic group II PLA 2 enzymes. The superimposition of ecarpholin S with a classic group II PLA 2 (ScPLA 2 ; Protein Data Bank code 1OZ6) gave a root mean-square deviation (rmsd) of 1.2 Å for 120 Ca atoms. Thus we will provide only a general overview of the structure and the subtle differences between ecarpholin S and other PLA 2 enzymes. Ecarpholin S consists of an N-terminal a-helix (a1), a loop equivalent to the Ca 21 -binding loop, two long antiparallel a-helices (a2 and a3), the short two-stranded antiparallel b-sheet (b-wing), and the C-terminal loop region. The sequence of ecarpholin S contains 14 cysteine residues, forming seven disulfide bonds. The pattern of disulfide bridges is identical to that of classic group II PLA 2 (5 did not bind to ecarpholin S (Fig. S3 in Data S1). No calcium FIGURE 1 Effects of ecarpholin S on levels of creatine kinase (CK) in mouse serum. Various doses of ecarpholin S (0 mg of ecarpholin S represents 50 mL of PBS buffer), with or without suramin, were injected into gastrocnemius muscles of mice, 3 h before their blood was collected. Released CK in plasma was measured, and results are presented as average 6 SD (n ¼ 5).
ion was found at the putative Ca 21 speculate that the point mutation of Ser 49 Asp alone in ecarpholin S may not restore its enzyme activity.
All catalytic residues are conserved in ecarpholin S. Critical residues of the catalytic triad of ecarpholin S (His 48 , Tyr 52 , and Asp 99 ) are anchored tightly to the scaffold composed of two a helices, and superimpose with corresponding residues of two structural homologues from Asp 49 and Lys
49
-PLA 2 enzymes with nearly identical conformations (rmsd of 0.5 Å ) (Fig. S4 in Data S1). The hydrophobic channel that provides access to the catalytic site is also highly conserved. Therefore, we propose that the nonideal conformation of the Ca 21 -binding loop is responsible for the low enzyme activity of ecarpholin S.
The structure of ecarpholin S shows several positively charged patches on the surface of the molecule (Fig. S5 in Data S1) that may interact with negatively charged counterparts on the membrane, to initiate the process of interrupting the integrity of the cell. For example, a Lys 49 -PLA 2 such as myotoxin I was shown to interrupt negatively charged liposomes in vitro (46) . To understand these interactions further, we studied the binding between PG and ecarpholin S, using SPR (Fig. 4) . Phosphatidyglycerol was immobilized to the surface of the L1 chip in the experiment, and ecarpholin S was the analyte. Sensorgrams show that PG binds to ecarpholin S in a dose-dependent manner. The dissociation constant (K D ) calculated from these sensorgrams was 0.5 mM.
Structure of ecarpholin S/lauric acid complex
Our crystallization experiments showed that ecarpholin S can be crystallized in different conditions. The structure of ecarpholin S in P3 1 21 crystal form was determined at a 1.95-Å resolution (R work ¼ 22.8%, and R free ¼ 26.8%). The model was refined with good stereochemical parameters ( Table 1) . During structural refinement, the hydrophobic channel of ecarpholin S showed an extra electron density to accommodate ;12 atoms. Because the crystallization conditions did not contain polyethylene glycol, and considering the extra electron density location, size, and geometry, this electron density was modeled as lauric acid (Fig. 5 A) , although no lauric acid was added during the experiments. However, no direct evidence is available to confirm the presence of lauric acid, and the assignment of the electron density to this molecule must be regarded with caution. We do not rule out the possibility of the binding of some other metabolite at this site. Moreover, in the presence of isopropanol (10-20%) in the crystallization conditions of the apo and suramin ecarpholin S complex (see below), no lauric acid was evident. Probably the naturally bound lauric acid was removed by the organic solvent present in the crystallization conditions, whereas the lauric-acid complex was crystallized with 2 M ammonium sulfate, and because of the high hydrophobic interactions, the lauric acid was retained in the hydrophobic channel of ecarpholin S.
The lauric acid was well-defined in the electron-density map (Fig. 5 A) . No calcium ion was identified at the putative Ca 21 -binding loop. The overall structure of ecarpholin S in the complex was similar to that of apo-ecarpholin S in P2 1 48 , whereas the tail of the ligand extends into the hydrophobic channel. The presence of such a natural fattyacid molecule was previously reported in the crystal structures of three different Lys 49 -PLA 2 enzymes (13,14,21). The superposition of the ecarpholin S/lauric acid complex on the known fatty-acid complexes indicates that all ligands are in the same region of PLA 2 enzymes (Fig. 6) , whereas the conformation of the alkyl tail is different. The alkyl tail of lauric acid of the ecarpholin S complex is close to the i-face, whereas the tails of the other three fatty acids take different orientations, closer to the N-terminal region. These three fatty acids are longer, and are in generally extended conformations. The observed electron density from Fo-Fc maps and simulated annealing omit maps did not permit us to model our ligand with an extended conformation. The ecarpholin S-bound lauric acid could be the result of phospholipid hy- drolysis by ecarpholin S, followed by a failure of product release. Alternatively, it could be a transient fatty acyl intermediate in the catalytic cycle that leads to the release of fatty acid in the next step.
The Fo-Fc and omit maps of the apo and ecarpholin S/suramin complex (see below) were carefully examined for the presence of any PEG or fatty-acid molecules in the hydrophobic channel, because both conditions used for crystallization contained PEG3350. In these structures, no electron densities could be modeled as either a fatty acid or a PEG molecule. It is important to note that the crystals for both the apo-enzyme and the lauric acid complex were obtained from the same batch of protein; the only difference involved their crystallization conditions. Watanabe et al. (47) obtained the MjTX-II/stearic acid complex from a cocrystallization experiment. In the hydrophobic channel of MjTX-II, a second stearic acid was observed in the vicinity of the first stearic acid, as shown in Fig. 6 . In the case of the ecarpholin S/lauric acid complex, no electron density was observed to model the second fatty acid or other polymeric molecules in the corresponding location. This result further suggests that lauric acid could be a natural ligand for ecarpholin S, specifically binding at one location of the hydrophobic channel. Thus, this complex appears to be different from the in vitro MjTX-II/ stearic acid complex (47) .
To understand these interactions further, we studied the interaction between lauric acid and ecarpholin S, using SPR (Fig. 4) . Sensorgrams showed that lauric acid binds to ecarpholin S in a dose-dependent manner, exhibiting characteristic slow-binding and slow-dissociation curves. The dissociation constant (K D ) calculated from these sensorgrams was 4.2 mM.
Structure of ecarpholin S/suramin complex
Suramin, a highly charged polysulfonated compound, inhibits the myonecrosis caused by some snake venoms and Lys 49 -PLA 2 enzymes (20, (48) (49) (50) . Similarly, suramin significantly inhibits the myotoxic activity of ecarpholin S ( 1). To understand these interactions, we determined the crystal structure of the ecarpholin S/suramin complex. Data for this complex were collected at a 2.3-Å resolution, and the structure was solved and refined to an R work of 21.7% (R free ¼ 27.5%). The model was refined with good stereochemical parameters ( Table 1) . Suramin molecules were well-defined in the electron-density map (Fig. 5 B) . No calcium ion was identified at the putative Ca 21 -binding loop. The asymmetric unit consists of eight ecarpholin S monomers, with 12 suramin molecules (3:2 inhibitor/protein ratio). The eight monomers could be divided into four dimers, each sandwiching three suramin molecules (Fig. 7) . The conformations of all eight monomers were nearly identical. The superimposition of apo ecarpholin S and the ecarpholin S/suramin complex gave an rmsd in the range of 0. 9-1.0 Å for all chains. Similarly, the rmsd for the lauric-acid complex molecule A (or B) and suramin complex was in the range of 0.6-0.8 Å for each molecule. Thus, the complex formation with suramin did not result in any significant conformational changes in the protein.
In the ecarpholin S/suramin complex, the entrance of the hydrophobic channel of monomers A and B of the dimer are occupied by three suramin molecules through hydrogenbonding and hydrophobic interactions. Most residues that form hydrogen bonds with suramin are located in the i-face (Fig. 8 A) . Suramin also interacts with the C-terminal region of ecarpholin S. In addition, Asn 114 , Lys 115 , and Lys 116 of monomer A form several hydrogen-bonding contacts with suramin (Fig. 8 B) . Suramin forms interactions with the N-terminal helix of ecarpholin S (Fig. 8 C) . Overall, the suraminrecognition sites of ecarpholin S are mainly from the i-face, C-terminal, and N-terminal regions through hydrogenbonding and hydrophobic interactions. In contrast, in the Lys 49 . In this case, suramin interacts with Basp-II, with a stoichiometric ratio of 1:1. Thus, in terms of the stoichiometric ratio and the interaction site, the ecarpholin S/suramin complex is different from that of the Basp-II/suramin complex. To test whether this observed difference is attributable to the ratios between suramin and ecarpholin S, we crystallized the complex at various suramin/protein ratios. The crystal complex structure remained the same at the 3:2 ratios (inhibitor/protein). In all crystal structures obtained, suramin molecules were fully occupied in all positions in the asymmetric unit described above. We think that the surplus protein present in the solution did not affect the crystallization of the ecarpholin S /suramin complex.
In the crystal structure, the ecarpholin S/suramin complex forms dimers as the minimal unit, and four dimers (octamers) are found in the asymmetric unit. This is consistent with gelfiltration experiments. In the gel filtration, the ecarpholin and suramin mixture eluted as a dimer (Fig. 9) , whereas ecarpholin S alone eluted as a monomer. This shows that suramin functions as a linker molecule between the monomers, and induces the dimerization of ecarpholin S, as revealed by the crystal structure.
The interaction of suramin with ecarpholin S was further examined by preliminary ITC experiments. The binding isotherm and nonlinear least-squares analysis of the data are shown in Fig. 10. Fig. 10 , top shows the heat effect associated with successive injections until saturation is reached. Fig. 10 , bottom shows the integrated heat effects associated with each injection. In the analysis, the concentration of ecarpholin S was considered on the basis of monomers. The titration was nonmonotonic, exhibiting a biphasic shape that does not correspond with stoichiometries for independent binding sites. This biphasic shape is not considered an artifact, because it always appeared and can be accounted for with the binding model used in the analysis. Moreover, blank titrations that injected ligand into the buffer yielded constant heat effects.
Because the gel-filtration and x-ray diffraction results indicated that suramin promotes dimerization, and the stoichiometry is 3:1 (suramin/dimer), the simplest way to analyze titration is to consider a fully cooperative twostate model in which n ligand molecules bind to a dimer at once. Then, only two states are present: a free protein monomer, and a dimer with n bound ligands. The chemical equilibrium scheme for this model, as been outlined in the Appendix, is:
where the dimerization energetics are implicitly included in the binding energetics, and no intermediate states appear. Thus, the global-equilibrium constant will be a combination of the equilibrium constant for ligand binding, K L , and the equilibrium constant for dimerization, K d : 
and the global enthalpy will be a combination of the ligandbinding enthalpy, DH L , and the dimerization enthalpy, DH d :
If it is assumed that an ecarpholin dimer binds three ligand molecules (n ¼ 3), the nonlinear analysis yields the following values: K ¼ (2.1 6 0.6) 3 10 20 (M À4 ), DH ¼ À27 6 1 kcal/ mol, N ¼ 0.69 6 0.05. The theoretical curve is able to reproduce the experimental curve reasonably well, including the initial part of the titration where the heat effect slightly increases. Because the parameter N corrects for the effective concentration of protein, there are two possible explanations for N not being equal to unity: (1), assuming that the suramin concentration is accurately determined, only 70% of the protein is binding-competent; or (2), less than three suramin molecules bind per dimer under the conditions and concentrations used in the ITC experiments. If it is assumed that an ecarpholin dimer binds two ligand molecules (n ¼ 2), the nonlinear analysis yields the following values: K ¼ (1.9 6 0.3) 3 10 14 (M À3 ), DH ¼ À26.7 6 0.8 kcal/mol, N ¼ 1.09 6 0.05. Again, the theoretical curve is able to reproduce the experimental curve reasonably well, including the initial part of the titration where the heat effect slightly increases, and the fit is significantly better than the previous one with three ligand molecules bound per dimer.
The titration experiments cannot be analyzed with a model considering two or three independent binding sites (51), because the thermodynamic parameters obtained, and in particular the stoichiometry values, are not realistic (i.e., N values much lower than 1).
DISCUSSION
An explanation for the mechanism of lipid hydrolysis by Asp 49 -PLA 2 enzymes was proposed by Verheij et al. (52) , and was subsequently modified, based on the crystal structure of PLA 2 from Naja atra venom complexed with a transitionstate analogue (53, 54) . In those models, the roles of active sites, the Ca 21 -binding loop, the hydrophobic channel, and the i-face were established. A structural characterization of PLA 2 isoforms with low or no enzymatic activity will help us further understand the mechanism of catalysis. In a number of group II PLA 2 enzymes, one of the critical residues for Ca 21 49 , and other non-Asp 49 -PLA 2 enzymes show limited or no enzymatic activity, they exhibit strong myotoxic activities (including ecarpholin S). The mechanism of their action remains interesting, because it is believed to be independent of phospholipid hydrolysis activity. Many proposals were put forward to explain Lys 49 -PLA 2 myotoxic activity, and they were summarized in re- views (18, 19) . These myotoxins should have a specific ''functional site'' responsible for their potent myotoxic activities. Synthetic peptides (KKYRYYLKPLCKK and KKYKAYFKLKCKK) from the C-terminal region K115-K129 of B. asper myotoxin II and A. p. piscivorus Lys 49 PLA 2 , respectively, induce cytolytic effects and play a critical role in myotoxicity (15) (16) (17) 55) . This region was also identified as a binding site for heparin (a myotoxin inhibitor) in rat class IIA secreted PLA 2 (51) . Treatment with cyanogen bromide leads to cleavage of the N-terminal octapeptide of B. asper myotoxin II, resulting in a significant decrease in its membrane-damaging activities, such as liposome disruption and myotoxicity (56) (57) (58) . Thus, the N-terminal region is also responsible for myotoxicity. The ecarpholin S/suramin complex shows that it simultaneously binds to the C-terminal, N-terminal, and i-face. These findings strongly suggest that one or more of these three regions could be functionally relevant regions in myotoxicity. The comparison of C-terminal residues Lys 115 -Gly 129 (KKYTYYPNFWCKG) of ecarpholin S with the corresponding segment of B. asper myotoxin II and A. p. piscivorus Lys 49 -PLA 2 reveals that they possess combinations of positively charged and hydrophobic residues. In the ecarpholin S/suramin complex, suramin is mainly held together by a combination of both hydrogen-bonding and hydrophobic interactions with residues, such as Lys 115 , Lys 116 , Phe124, and Trp125. Because Lys 115 and Lys 116 are highly conserved among all three PLA 2 enzymes, they may play a more crucial role in the activity of myotoxic PLA 2 enzymes. Furthermore, our SPR experiments suggest that negatively charged phospholipids, such as PG, interact with ecarpholin S. Based on our studies, we propose a hypothesis to explain the myotoxic activity of ecarpholin S: positively charged residues, located in the i-face of the protein, initiate binding with the anionic acceptor(s) (phospholipids) on the membrane, leading to a further strengthening of this interaction by hydrophobic and aromatic residues located at the entrance of the hydrophobic channel. The C-terminal (mainly Lys 115 and Lys 116 ) and N-terminal positive patches interact further with the membrane, perturbing the membrane's integrity and inducing cell death. This hypothesis is highly consistent with evidence from noncrystallographic studies involving chemical modifications, synthetic peptides, inhibitors, and sitedirected mutagenesis (15) (16) (17) (55) (56) (57) (58) .
Our preliminary studies to characterize the thermodynamics of the ecarpholin/suramin interaction are in agreement with suramin promoting the dimerization of ecarpholin. The cooperative model, in which only two states are considered (free protein monomer and ligand-bound protein dimer), is able to describe qualitatively and quantitatively the calorimetric titrations reasonably well. According to our results, the ecarpholin dimer might bind two suramin molecules under the conditions and concentrations used for ITC experiments. Although three suramin molecules bound to an ecarpholin dimer are observed in the crystallographic structure, one of the three suramin molecules in every dimer has higher a B-factor, suggesting the possibility of partial occupancy. In addition, the protein and ligand concentrations are significantly higher in the crystallization setup. If two suramin molecules bind to a protein dimer, the global Gibbs energy is À19.8 kcal/mol, whereas if three suramin molecules bind to a protein dimer, the global Gibbs energy is À28.2 kcal/mol. This global Gibbs energy corresponds to the Gibbs energy for the binding of two or three ligand molecules plus the Gibbs energy for ecarpholin dimerization. The enthalpy values obtained from the analysis are observed values with a possible influence on the ionization enthalpy of the buffer. Additional experiments would be required to assess the extent of possible protonation events coupled to ligand binding, and to estimate the buffer-independent binding enthalpies.
The fully cooperative two-state model for suramin binding can reproduce the shape of the experimental titrations, which supports the hypotheses that suramin promotes dimerization and the population of ligand-free dimers is not significant, as observed using gel-filtration chromatography. A more realistic model would include the ligand-free monomer-dimer equilibrium. A more detailed discussion about the adequate binding model would be appropriate in future work. The influence and explicit consideration of the protein monomerdimer equilibrium, modulated by ligand binding, would require additional information from ultracentrifugation experiments or binding experiments at different concentrations of protein, or by performing reverse titrations in which the protein is injected into the ligand solution.
In conclusion, the structure of the first representative member of the Ser 49 21 . Secondly, the ecarpholin S/suramin complex shows that, in addition to the i-face, suramin interacts with both the C-terminal and N-terminal regions of ecarpholin S. Such interactions were not observed in the previous report of the Lys 49 -PLA2/suramin complex (20) . These findings broaden the understanding of the action of non-Asp 49 -PLA 2 enzymes, and should be helpful in the development of new drugs for the treatment of myonecrosis.
APPENDIX
The procedure for the analysis of ITC experiments, according to the cooperative model (Eq. 1), is rather straightforward, starting from the conservation equations for protein and ligand:
where M and L represents the protein monomer and the ligand molecule, respectively. The global-equilibrium constant, K, governs the partition into bound and free species:
where K L is the equilibrium constant for ligand binding, and K d is the dimerization constant for the protein. Therefore, Eq. 4 can be written in terms of free concentrations:
The free concentration of protein, [M] , can be calculated by solving analytically the first equation of the previous set:
FIGURE 10 Interaction between ecarpholin S and suramin, using ITC. Raw thermal power signal (top) and plot of integrated heat versus ligand/ protein molar ratio (bottom). Conditions: 0.03 mM ecarpholin S titrated with 5-mL injections of 0.5 mM suramin. Both protein and suramin solutions were in 50 mM Tris-HCl at pH 7.0 and 30°C. In the analysis, protein concentration was considered on a monomer basis (0.03 mM). Titration curve was analyzed using a fully cooperative model in which n ligand molecules (n ¼ 
½M ¼
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and it can be introduced into the second equation of the previous set, to calculate the free-ligand concentration, [L]:
which can be solved numerically (e.g., by the Newton-Raphson method).
Once the free-ligand and free-protein concentrations are known, the concentration of the complex can be calculated from Eq. 5:
The concentration of total ligand and total protein in the calorimetric cell after each injection i is calculated as:
where [L] 0 is the concentration of ligand in the syringe, [M] 0 is the initial concentration of protein in the cell, and v and V are the injection volume and the cell volume, respectively. The factor (1 À v/V) is the dilution factor after each injection. Given the total concentration of protein and ligand in the calorimetric cell before and after each injection (Eq. 10), and assuming a certain value for the equilibrium constant K, the concentration of free ligand and free protein, before and after each injection, can be calculated by solving Eqs. 7 and 8, and the concentration of the complex can be calculated from Eq. 9. Then the heat q i associated with the injection i is calculated for the sequential ligandbinding model:
where DH is the global enthalpy (Eq. 3), and q d is the so-called ''dilution heat'' (constant background heat effect due to unspecific phenomena such as ligand dilution upon injection and injection turbulence). Nonlinear leastsquare regression, using Eq. 11, will provide K and DH as adjustable parameters. It is customary to include an additional parameter N (i.e., using N[M] T instead of [M] T in all previous equations) to account for a different stoichiometry than the one expected or a mismatch between the measured concentrations and the actual ones.
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